Shandong Xinhua Pharmaceutical Co Ltd Capital Reinvestment Ratio
Shandong Xinhua Pharmaceutical Co Ltd capital reinvestment ratio. Shandong Xinhua Pharmaceutical Co Ltd (000756) has a Capital Reinvestment Ratio of 1.44x as of September 2023, meaning it reinvests 1% of its operating cash flow (CN¥56.11 Million) in capital expenditures (CN¥80.69 Million). See 000756 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shandong Xinhua Pharmaceutical Co Ltd (2015–2024)
Capital reinvestment ratio of Shandong Xinhua Pharmaceutical Co Ltd from 2015 to 2024. This chart tracks Shandong Xinhua Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 10 annual periods. See 000756 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Shandong Xinhua Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2015–2024)
Shandong Xinhua Pharmaceutical Co Ltd capital reinvestment ratio by year from 2015 to 2024. For the full cash flow conversion analysis, see Shandong Xinhua Pharmaceutical Co Ltd cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.58x | CN¥367.61 Million | CN¥212.42 Million | ▼ -52.9% |
| 2023 | 1.23x | CN¥265.28 Million | CN¥325.13 Million | ▲ +279.7% |
| 2022 | 0.32x | CN¥758.24 Million | CN¥244.76 Million | ▼ -66.4% |
| 2021 | 0.96x | CN¥259.12 Million | CN¥249.23 Million | ▲ +44.2% |
| 2020 | 0.67x | CN¥420.19 Million | CN¥280.19 Million | ▼ -36.6% |
| 2019 | 1.05x | CN¥348.27 Million | CN¥366.51 Million | ▼ -12.2% |
| 2018 | 1.20x | CN¥323.91 Million | CN¥388.44 Million | ▲ +79.1% |
| 2017 | 0.67x | CN¥389.97 Million | CN¥261.11 Million | ▲ +29.6% |
| 2016 | 0.52x | CN¥439.35 Million | CN¥227.07 Million | ▲ +6.6% |
| 2015 | 0.48x | CN¥348.64 Million | CN¥169.09 Million | — |